Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies

G Patel, S Huprikar, SH Factor, SG Jenkins… - Infection Control & …, 2008 - cambridge.org
Background.Carbapenem-resistant Klebsiella pneumoniae is an emerging healthcare-associated
pathogen.Objective.To describe the epidemiology of and clinical outcomes associated …

[HTML][HTML] “Stormy waters ahead”: global emergence of carbapenemases

G Patel, R Bonomo - Frontiers in microbiology, 2013 - frontiersin.org
Carbapenems, once considered the last line of defense against of serious infections with
Enterobacteriaceae, are threatened with extinction. The increasing isolation of carbapenem-…

Introductions and early spread of SARS-CoV-2 in the New York City area

…, F Krammer, A García-Sastre, M Luksza, G Patel… - Science, 2020 - science.org
New York City (NYC) has emerged as one of the epicenters of the current severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To identify the early transmission …

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

…, GM Lyon, LE Bell, S Huprikar, G Patel… - The Lancet infectious …, 2010 - thelancet.com
Background There are few data on the epidemiology and outcomes of influenza infection in
recipients of solid-organ transplants. We aimed to establish the outcomes of pandemic …

[HTML][HTML] Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants

…, H Alshammary, S Schaefer, G Patel… - Nature …, 2023 - nature.com
Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have
been reported in immune-compromised individuals and people undergoing immune-…

[HTML][HTML] Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study

…, M Mansour, E Leven, NM Bouvier, G Patel… - The Lancet …, 2020 - thelancet.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
global pandemic. The proportion of infected individuals who seroconvert is still an open …

Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United …

MJ Satlin, L Chen, G Patel… - Antimicrobial agents …, 2017 - Am Soc Microbiol
Although the New York/New Jersey (NY/NJ) area is an epicenter for carbapenem-resistant
Enterobacteriaceae (CRE), there are few multicenter studies of CRE from this region. We …

Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity

…, S Sharma, SP Blash, G Patel… - Infection Control & …, 2013 - cambridge.org
Objective.To describe the epidemiology of carbapenem-resistant Enterobacteriaceae (CRE)
carriage and acquisition among hospitalized patients in an area of CRE endemicity.Design.…

In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin

A Endimiani, G Patel, KM Hujer… - Antimicrobial agents …, 2010 - Am Soc Microbiol
In vitro activity of fosfomycin was evaluated against 68 bla KPC -possessing Klebsiella
pneumoniae (KpKPC) isolates, including 23 tigecycline- and/or colistin-nonsusceptible strains. By …

Status report on carbapenemases: challenges and prospects

G Patel, RA Bonomo - Expert review of anti-infective therapy, 2011 - Taylor & Francis
Antimicrobial resistance in hospital and community-onset bacterial infections is a significant
source of patient morbidity and mortality. In the past decade, we have witnessed the …